{
  "id": "e1b3cdae1d3ec24d",
  "title": "An Overview of the 2025 National Drug Price Negotiations and NRDL",
  "description": "20260212T231500Z",
  "content": "",
  "source": "natlawreview.com",
  "source_url": "https://natlawreview.com/article/china-move-key-takeaways-2025-nrdl-negotiations-and-adjustment",
  "published_at": "20260212T231500Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://natlawreview.com/article/china-move-key-takeaways-2025-nrdl-negotiations-and-adjustment",
    "url_mobile": "https://natlawreview.com/article/china-move-key-takeaways-2025-nrdl-negotiations-and-adjustment?amp",
    "title": "An Overview of the 2025 National Drug Price Negotiations and NRDL",
    "seendate": "20260212T231500Z",
    "socialimage": "https://natlawreview.com/sites/default/files/styles/article_image/public/2026-02/healthcare%20insurance%20food%20and%20drug%20administration%20pharmaceutical%20industry%20prescription%20drug%20multicolored%20pills.jpg.webp?itok=vqTWMlsl",
    "domain": "natlawreview.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}